Phibio GmbH
Congress Stand 52
Category: Hyaluronic acid-based injectable medical devices and therapeutic solutions
https://phibio.de
+49 1520 7659955
[email protected]
Phibio GmbH is a German biotechnology and medical technology company specialising in the development and production of innovative injectable medical devices, with a particular focus on hyaluronic acid-based solutions. Its portfolio includes products for orthopaedics, ophthalmology, and dermatology, designed to meet the evolving needs of healthcare professionals and patients. Combining scientific expertise, and advanced biotechnology Phibio is committed to delivering high-quality, reliable solutions and building long-term partnerships with healthcare professionals, distributors, and industry partners worldwide.
Product
Name: ViscoPhi, ViscoPhi Cross and ViscoPhi Trio
Type: Intraarticular Injection
Summary: ViscoPhi™ is a sterile ready-to-use intra-articular viscoelastic implant gel solution to treat human joint disorders such as osteoarthritis